Tomasz C.
- Country
- Poland
- Department
- cardiology department
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
Data & Insights
Has run more than one trial at 576 of 1141 partner sites.
Specializations
Cardiac Function Management
The investigator specializes in treating patients with chronic heart failure, particularly focusing on various ejection fraction presentations including reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).
- Heart failure progression management
- Cardiac function optimization
- Novel therapeutic approaches for heart failure
Their research encompasses evaluating innovative treatments for improving cardiac performance and patient outcomes.
Cardiac Rhythm Disorders
The investigator has significant expertise in managing atrial fibrillation and its associated complications, with particular emphasis on stroke prevention strategies.
- Stroke prevention in atrial fibrillation
- Systemic embolism management
- Anticoagulation therapy evaluation
Their work includes assessment of novel anticoagulant treatments for preventing cardiovascular complications.
Cardiovascular Therapeutics
The investigator focuses on evaluating innovative cardiovascular medications and their applications in treating complex cardiac conditions.
- Novel drug tolerance assessment
- Comparative treatment efficacy
- Safety profile evaluation
Their expertise extends to investigating therapeutic approaches for various cardiovascular conditions requiring specialized treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.